Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Plum-Moerschel, Leona
Heise, Tim
Zijlstra, Eric
Lyby, Karsten
Wassermann, Karsten
Brondsted, Lise
Halberg, Inge Birk
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
380-OR
引用
收藏
页码：A100 / A100
页数：1
相关论文
共 50 条
  • [41] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A102 - A102
  • [42] Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia
    Parra-Mujica, Fiorella
    Roope, Laurence S. J.
    Abdul-Aziz, Alia
    Mustapha, Feisul
    Ng, Chiu Wan
    Rampal, Sanjay
    Lim, Lee-Ling
    Dakin, Helen
    Clarke, Philip
    SOCIAL SCIENCE & MEDICINE, 2024, 340
  • [43] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
    Shafie, Asrul Akmal
    Ng, Chin Hui
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
  • [44] CLINICAL EXPERIENCES OF TYPE 2 DIABETES (T2DM) PATIENTS INITIATING ORAL SEMAGLUTIDE
    Dunn, T. J.
    Swift, C.
    Guesnier, A.
    Noone, J.
    Willey, V
    VALUE IN HEALTH, 2022, 25 (07) : S309 - S309
  • [45] Looking for Predictors of Successful Basal Insulin Titration in T2DM
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    DIABETES, 2016, 65 : A252 - A252
  • [46] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Raccah, Denis
    Haak, Thomas
    Huet, Dominique
    Monnier, Louis
    Penfornis, Alfred
    Robertson, Douglas
    Labard, Pascale
    Soler Ramon, Juan
    DIABETES, 2010, 59 : A151 - A151
  • [47] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): A SUB ANALYSIS OF ATOS STUDY
    Khan, N.
    Al Shaikh, A. R.
    Hassoun, A.
    Mabunay, M. A. N.
    Magdy, A.
    Salah, M.
    Al Abdella, N.
    Safarini, S.
    Al Dahi, W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A102 - A103
  • [48] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [49] The Efficacy and Safety of Careful Management of Self-Dose-Adjustment Intervention of Basal Insulin by the Nurse in Outpatients with T2DM
    Hu, Xiling
    Yang, Xubin
    Deng, Hongrong
    Guo, Xiaodi
    Yao, Bin
    DIABETES, 2019, 68
  • [50] TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) WITH SITAGLIPTIN-EFFICACY AND SAFETY IN A REAL-LIFE SETTING
    Kusterer, K.
    Ruessmann, H. J.
    Hens, C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 52 - 52
12345